CeriBell, Inc. Common Stock CBLL
Analyst Ratings
- Consensus
- Buy — 4 Buy · 0 Hold · 0 Sell (4 analysts)
- Avg. Price Target
- $26.50 (-2.4% downside)
Key Stats
- Today's Range
- $27.01 – $28.11
- 50-Day Range
- $21.06 – $28.11
- 52-Week Range
- $10.85 – $28.11
- Volume
- 472K shs
- Average Volume
- 423K shs
- Market Cap
- $1.06 billion
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.47%
- Days to Cover
- 1.00
About CeriBell, Inc. Common Stock
CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.
Related Stocks
Compare head-to-head: CBLL vs MDT·CBLL vs AXGN·CBLL vs CNMD·CBLL vs ELMD
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.